Cargando…

Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation

Multiple sclerosis (MS) is an autoimmune inflammatory disease characterized by demyelination, axonal loss, and synaptic impairment in the central nervous system (CNS). The available therapies aim to reduce the severity of the pathology during the early inflammatory stages, but they are not effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roggeri, Alessandra, Schepers, Melissa, Tiane, Assia, Rombaut, Ben, van Veggel, Lieve, Hellings, Niels, Prickaerts, Jos, Pittaluga, Anna, Vanmierlo, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588977/ https://www.ncbi.nlm.nih.gov/pubmed/33066042 http://dx.doi.org/10.3390/ijms21207537

Ejemplares similares

From OPC to Oligodendrocyte: An Epigenetic Journey
por: Tiane, Assia, et al.
Publicado: (2019)

DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation
por: Tiane, Assia, et al.
Publicado: (2021)

From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions
por: Tiane, Assia, et al.
Publicado: (2023)

Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
por: Schepers, Melissa, et al.
Publicado: (2019)

A perspective on causality assessment in epigenetic research on neurodegenerative disorders
por: Koulousakis, Philippos, et al.
Publicado: (2022)

Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720
por: Roggeri, Alessandra, et al.
Publicado: (2023)

PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
por: Rombaut, Ben, et al.
Publicado: (2021)

Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders
por: Spaas, Jan, et al.
Publicado: (2021)

Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology
por: Paes, Dean, et al.
Publicado: (2023)

Edible seaweed-derived constituents: an undisclosed source of neuroprotective compounds
por: Schepers, Melissa, et al.
Publicado: (2019)

Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury
por: Mussen, Femke, et al.
Publicado: (2023)

Neuroinflammation in Ischemic Stroke: Inhibition of cAMP-Specific Phosphodiesterases (PDEs) to the Rescue
por: Ponsaerts, Laura, et al.
Publicado: (2021)

24(S)-Saringosterol Prevents Cognitive Decline in a Mouse Model for Alzheimer’s Disease
por: Martens, Nikita, et al.
Publicado: (2021)

Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic
por: Olivero, Guendalina, et al.
Publicado: (2023)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Editorial: Neuro-Immune Connections to Enable Repair in CNS Disorders
por: Vanmierlo, Tim, et al.
Publicado: (2020)

Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond
por: Zhang, Shuo-Qi, et al.
Publicado: (2021)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System
por: Pittaluga, Anna, et al.
Publicado: (2021)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Novel insights in phosphodiesterase 4 subtype inhibition to target neuroinflammation and stimulate remyelination
por: Schepers, Melissa, et al.
Publicado: (2023)

Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2021)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Beyond Myelination: Possible Roles of the Immune Proteasome in Oligodendroglial Homeostasis and Dysfunction
por: Madeira, Miguel M., et al.
Publicado: (2022)

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
por: Ceccom, Johnatan, et al.
Publicado: (2014)

FTY720 Story. Its Discovery and the Following Accelerated Development of Sphingosine 1-Phosphate Receptor Agonists as Immunomodulators Based on Reverse Pharmacology
por: Adachi, Kunitomo, et al.
Publicado: (2007)

Cardioprotective Effects of Sphingosine-1-Phosphate Receptor Immunomodulator FTY720 in a Clinically Relevant Model of Cardioplegic Arrest and Cardiopulmonary Bypass
por: Ahmed, Naseer, et al.
Publicado: (2019)

Correction to: Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2021)

Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
por: Mishima, Yuko, et al.
Publicado: (2018)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
por: Pierucci, Federica, et al.
Publicado: (2023)

Feeding Stimulates Sphingosine-1-Phosphate Mobilization in Mouse Hypothalamus
por: Vozella, Valentina, et al.
Publicado: (2019)

Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update
por: Olivero, Guendalina, et al.
Publicado: (2020)

Sphingosine Kinases/Sphingosine-1-Phosphate and Death Signalling in APP-Transfected Cells
por: Gassowska, Magdalena, et al.
Publicado: (2014)

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina
por: Porter, Hunter, et al.
Publicado: (2018)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Dietary Sargassum fusiforme improves memory and reduces amyloid plaque load in an Alzheimer’s disease mouse model
por: Bogie, Jeroen, et al.
Publicado: (2019)

Sphingosine‐1‐phosphate improves outcome of no‐reflow acute myocardial infarction via sphingosine‐1‐phosphate receptor 1
por: Polzin, Amin, et al.
Publicado: (2022)

Commentary: The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension
por: Bhavanam, Naga P., et al.
Publicado: (2015)

Flotillin proteins recruit sphingosine to membranes and maintain cellular sphingosine-1-phosphate levels
por: Riento, Kirsi, et al.
Publicado: (2018)

Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia
por: Dobierzewska, Aneta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4buam7lfi3mj6ij9aed2nu4l60